David Connelly
Chief Executive Officer

David Connelly has over 20 years’ experience in the pharmaceutical and CRO industry in areas including clinical trial design, operations, monitoring, biostatistics and data management. Dr Connelly also has extensive experience of working with top pharmaceutical company executives in process re-engineering, performance and change management, design and deployment of new technology.

Before founding Cmed in early 2000, Dr Connelly was Global Head of Data Management at Novartis. Dr. Connelly has a PhD in Pharmacology and has lived and worked in the UK, Switzerland and the US.

Timothy Corbett-Clark
Chief Technical Officer

Timothy Corbett-Clark is the leading technical force driving Cmed’s cutting edge Timaeus system. This has given rise to a world class solution which, according to experts at several of the world’s leading pharmaceutical companies, has unique “bottom line” benefits in today’s marketplace.

Dr Corbett-Clark has a first class honors degree in Engineering and Computing Science from the University of Oxford. In addition to being a “Scholar” and winning numerous prizes, he also completed his doctorate at the Oxford University Engineering Department. His D.Phil. thesis progressed understanding in rigorous approaches to Explanation from Artificial Neural Networks, and involved novel ideas in the areas of statistics, modeling in high dimensional spaces, computer science algorithms, and software development practices.

Dr Corbett-Clark was a co-founder of Third Phase Ltd, and joined Cmed in February 2002 when Third Phase Ltd was acquired by Cmed and became Cmed Technology Ltd.

Gareth Hughes
Chief Officer Corporate Business Management

Gareth Hughes has over 15 years’ experience in the pharmaceutical, consulting and CRO industries. With a background in data management systems and technical support services, Mr Hughes has been a business owner since 1997, when he formed his own consultancy providing technical support and special project services to big Pharma clients in Europe (including data management and SAS programming resource). In 2000, the consulting company came together by friendly acquisition to form the consulting division within the Cmed Group.

Mr Hughes has held the positions of Director, IT Operations, CEO Cmed US and more recently Head of Corporate Information.

Andrew Griffiths
Chief Operations Officer

Andrew Griffiths has over 20 years experience in the pharmaceutical and CRO industries. Before joining Cmed in 2004, Dr Griffiths served as Senior Vice President, Clinical Pharmacology at ICON Clinical Research. At ICON, Dr Griffiths also worked as Vice President, Business Development (Europe) and Head of European Operations. Before joining ICON he held posts in Programme Management and Clinical Research with Boots Pharmaceuticals and Abbott Laboratories respectively.

He has extensive experience of drug development and the design/management/conduct of clinical research in most therapeutic areas in many geographic locations (Europe, US and ROW). Dr Griffiths has a PhD in Clinical Pharmacology and has lived and worked in the UK and US.

Alan Eggleston
Global Head of Key Accounts

Alan Eggleston has more than 20 years experience in the pharmaceutical and CRO industries. Dr Eggleston is a qualified physician who, over time, has made the transition across the industry from the technical side (Medical Adviser for the Wellcome Foundation and Medical Director (SEAsia) for Sandoz) to the commercial side (Marketing Manager for the Wellcome Foundation and GlaxoWellcome).

In September 2007 he joined Cmed from PPD, the world’s largest, publicly quoted CRO, where he was VP, Business Development for Europe and ROW.

Stephanie Langouet
Global Head of Biometrics

Stephanie Langouet joined Cmed from Amgen, a leading international biotechnology company, in April 2009 as Global Head of Biometrics. She has degrees in Computer Science and Physiology. Since graduation her career has been in data management, programming, data systems and validation, process and change management, compliance and performance management. She has worked for Pharmaceutical, Biotech and CRO organizations in roles of increasing responsibility and has lived in the US, Canada, UK, Norway and France.